Fast Market Research

New Market Study, "Pfenex Inc. - Product Pipeline Review - 2013", Has Been Published

Fast Market Research recommends "Pfenex Inc. - Product Pipeline Review - 2013" from Global Markets Direct, now available

 

Boston, MA -- (ReleaseWire) -- 02/04/2014 -- Global Market Direct's pharmaceuticals report, "Pfenex Inc. - Product Pipeline Review - 2013" provides data on the Pfenex Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Pfenex Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from Pfenex Inc. and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- Pfenex Inc. - Brief Pfenex Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Pfenex Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Pfenex Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Pfenex Inc.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

View Full Report Details and Table of Contents

Reasons to Get This Report

- Evaluate Pfenex Inc.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Pfenex Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Pfenex Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Pfenex Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Pfenex Inc. and identify potential opportunities in those areas.

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Anthrax - Pipeline Review, H1 2013
- Growth Hormone Deficiency - Pipeline Review, H2 2013
- Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H2 2013
- Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H1 2013
- Neutropenia - Pipeline Review, H1 2013
- Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H1 2013
- Neutropenia - Pipeline Review, H2 2013
- Chemotherapy Induced Neutropenia - Pipeline Review, H1 2013
- Hanmi Pharmaceuticals, Co. Ltd. - Product Pipeline Review - 2013
- Growth Hormone Deficiency - Pipeline Review, H1 2013